Literature DB >> 16181339

Asparaginyl endopeptidase: case history of a class II MHC compartment protease.

Colin Watts1, Stephen P Matthews, Daniela Mazzeo, Bénédicte Manoury, Cathy X Moss.   

Abstract

Although the endpoint of the class II antigen-processing pathway is well characterized, the processing events that lead to the production of class II major histocompatibility complex (MHC)/peptide complexes are not. It is generally assumed that protease action on native antigen substrates leads to unfolding and capture of either long or short peptides. Whether specific protease activities are needed for presentation of particular T-cell epitopes is largely unknown. Here, we review our recent studies that aim to identify the processing enzymes that initiate processing of different antigens. We suggest a general strategy that can potentially identify preferred relationships between substrates and processing enzymes in vitro and suggest ways in which these relationships can be tested in vivo. We draw heavily on the example of asparaginyl endopeptidase, which is involved in both productive and destructive processing of different antigen substrates. Overall, while there is undoubtedly redundancy in class II MHC antigen processing, the contributions of individual enzymes can be clearly dissected.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16181339     DOI: 10.1111/j.0105-2896.2005.00312.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  18 in total

Review 1.  Beyond the classical: influenza virus and the elucidation of alternative MHC class II-restricted antigen processing pathways.

Authors:  Laurence C Eisenlohr; Nancy Luckashenak; Sebastien Apcher; Michael A Miller; Gomathinayagam Sinnathamby
Journal:  Immunol Res       Date:  2011-12       Impact factor: 2.829

2.  A dyad of lymphoblastic lysosomal cysteine proteases degrades the antileukemic drug L-asparaginase.

Authors:  Naina Patel; Shekhar Krishnan; Marc N Offman; Marcin Krol; Catherine X Moss; Carly Leighton; Frederik W van Delft; Mark Holland; Jizhong Liu; Seema Alexander; Clare Dempsey; Hany Ariffin; Monika Essink; Tim O B Eden; Colin Watts; Paul A Bates; Vaskar Saha
Journal:  J Clin Invest       Date:  2009-06-08       Impact factor: 14.808

Review 3.  Endolysosomal proteases and their inhibitors in immunity.

Authors:  Phillip I Bird; Joseph A Trapani; José A Villadangos
Journal:  Nat Rev Immunol       Date:  2009-12       Impact factor: 53.106

Review 4.  Proteolysis mediated by cysteine cathepsins and legumain-recent advances and cell biological challenges.

Authors:  Klaudia Brix; Joseph McInnes; Alaa Al-Hashimi; Maren Rehders; Tripti Tamhane; Mads H Haugen
Journal:  Protoplasma       Date:  2014-11-16       Impact factor: 3.356

5.  Asparaginyl endopeptidase cleaves TDP-43 in brain.

Authors:  Jeremy H Herskowitz; Yair M Gozal; Duc M Duong; Eric B Dammer; Marla Gearing; Keqiang Ye; James J Lah; Junmin Peng; Allan I Levey; Nicholas T Seyfried
Journal:  Proteomics       Date:  2012-08       Impact factor: 3.984

6.  IrAE: an asparaginyl endopeptidase (legumain) in the gut of the hard tick Ixodes ricinus.

Authors:  Daniel Sojka; Ondrej Hajdusek; Jan Dvorák; Mohammed Sajid; Zdenek Franta; Eric L Schneider; Charles S Craik; Marie Vancová; Veronika Buresová; Matthew Bogyo; Kelly B Sexton; James H McKerrow; Conor R Caffrey; Petr Kopácek
Journal:  Int J Parasitol       Date:  2007-01-30       Impact factor: 3.981

7.  Tumor proteomics by multivariate analysis on individual pathway data for characterization of vulvar cancer phenotypes.

Authors:  Annsofi Sandberg; Gunnel Lindell; Brita Nordström Källström; Rui Mamede Branca; Kristina Gemzell Danielsson; Mats Dahlberg; Barbro Larson; Jenny Forshed; Janne Lehtiö
Journal:  Mol Cell Proteomics       Date:  2012-04-12       Impact factor: 5.911

8.  Immunodominance of CD4 T cells to foreign antigens is peptide intrinsic and independent of molecular context: implications for vaccine design.

Authors:  Jason M Weaver; Christopher A Lazarski; Katherine A Richards; Francisco A Chaves; Scott A Jenks; Paula R Menges; Andrea J Sant
Journal:  J Immunol       Date:  2008-09-01       Impact factor: 5.422

Review 9.  Cathepsin G: roles in antigen presentation and beyond.

Authors:  Timo Burster; Henriette Macmillan; Tieying Hou; Bernhard O Boehm; Elizabeth D Mellins
Journal:  Mol Immunol       Date:  2009-11-11       Impact factor: 4.407

10.  The human G1m1 allotype associates with CD4+ T-cell responsiveness to a highly conserved IgG1 constant region peptide and confers an asparaginyl endopeptidase cleavage site.

Authors:  M M Stickler; A Reddy; J M Xiong; P R Hinton; R DuBridge; F A Harding
Journal:  Genes Immun       Date:  2011-02-17       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.